Concurrent Sorafenib Therapy Extends the Interval to Subsequent TACE for Patients With Unresectable Hepatocellular Carcinoma

YanqingZhao

Presentation information

Scientific Paper

Liver

[OS19] Liver4

Fri. May 19, 2017 9:54 AM - 10:48 AM Room5 (Okayama Convention Center 3F Conference room 301)

座長：南哲弥(金沢大学附属病院　放射線科)

10:21 AM - 10:30 AM

[一般演題19] Concurrent Sorafenib Therapy Extends the Interval to Subsequent TACE for Patients With Unresectable Hepatocellular Carcinoma

^○YanqingZhao, XuesongYao, DongYan, HuiyingZeng, DezhongLiu, HuaiLi (Department of Interventional Radiology,Cancer Hospital, Chinese Academy of Medical Sciences
and Peking Union Medical College, China)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.